Bristol-Myers Squibb Co. (NYSE:BMY) currently has a daily average trading volume of 15.90M but it saw 10914734 shares traded in last market. With a market cap of 97.89B USD, the company’s current market price of $48.30 came rising about 0.96 while comparing to the previous closing price of $47.84. In past 52 weeks, the stock remained buoying in the range of price level as high as $70.93 and as low as $47.58.
Taking a look at 20-day trading activity of Bristol-Myers Squibb Co. (BMY) gives us an average price of $50.99, while its current price level is -31.91% below from 52-week high level whereas it is 1.51% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $51.11 while that of 200 days or SMA-200 reads an average of $54.57. A closer look into the stock’s movement over the week reveals that its volatility is standing at 1.59% during that period while stretching the period over a month that increases to 1.69%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 33.72 which implies that the stock is in neutral territory.
Redburn Atlantic downgraded its recommendation for the stock as a “Neutral” from “Buy” on February 06, 2024 while assigning a price target range of $77-$54. BofA Securities also issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $68 and $60.
Over the week, BMY’s stock price is moving -1.67% down while it is -6.76% when we observe its performance for the past one month. Year-to-date it is -5.87% down and over the past year, the stock is showing a downside performance of -31.23%.
Currently, Bristol-Myers Squibb Co.’s total number of outstanding shares is 2.03B. Company’s return on investment (ROI) stands at 11.87% and return on equity (ROE) at 26.53%. It has a price to earnings ratio (P/E ratio) of 12.52 while having a 6.85 of forward P/E ratio. Stock’s beta reads 0.42. Stock has a price to book (P/B) ratio of 3.32 while price to sale or P/S ratio amounts to 2.18. Its return on asset (ROA) is 8.36% on average.
